<SEC-DOCUMENT>0000947871-15-000713-index.html : 20151002 <SEC-HEADER>0000947871-15-000713.hdr.sgml : 20151002 <ACCEPTANCE-DATETIME>20151002172528 ACCESSION NUMBER: 0000947871-15-000713 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20151002 DATE AS OF CHANGE: 20151002 GROUP MEMBERS: ORBIMED CAPITAL GP V LLC GROUP MEMBERS: SAMUEL D. ISALY SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics AG CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: C4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-89113 FILM NUMBER: 151141438 BUSINESS ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 BUSINESS PHONE: 43 (0)1 740 93-0 MAIL ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ORBIMED ADVISORS LLC CENTRAL INDEX KEY: 0001055951 IRS NUMBER: 133976876 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 601 LEXINGTON AVENUE STREET 2: 54TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 739-6400 MAIL ADDRESS: STREET 1: 601 LEXINGTON AVENUE STREET 2: 54TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13D <SEQUENCE>1 <FILENAME>ss454757_sc13d.htm <DESCRIPTION>SCHEDULE 13D <TEXT> Document 1 - file: ss454757_sc13d.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ss454757_ex9901.htm <DESCRIPTION>JOINT FILING AGREEMENT <TEXT> Document 2 - file: ss454757_ex9901.htm
</DOCUMENT> </SEC-DOCUMENT>